Advanced BioDesign

Advanced BioDesign

Advanced BioDesign

Advanced BioDesign is a young innovative company developing solutions addressed at solving issues on cell apoptosis, which is at the origin of its R&D in discovery of anticancer molecules and on detection of infectious diseases.
Type
B2c
Founded
2010
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€9,000,000
Venture capital - 2020
Xerys Funds
Team Size
1–10
Employees
Location
Headquarters
€9,000,000 Venture capital
FinSMEs

Advanced BioDesign Raises Additional €9M Financing